Feedback
  • Log In
  • Account Access
  • Contact Us

    Pre-Sales Support

    Mutual Funds and ETFs - 800-456-7526
    Monday-Thursday: 8:00 a.m. – 6:00 p.m. ET
    Friday: 8:00 a.m. – 5:00 p.m. ET

    ETF Trading Support - 415-315-6600
    Monday-Friday: 9:30 a.m. – 5:00 p.m. ET

    Post-Sales and Website Support
    888-843-7824
    Monday-Friday: 9:00 a.m. - 6:00 p.m. ET

Home
>
Funds
>
Hartford Healthcare Fund

Hartford Healthcare Fund

Explore Another ETFs

  • 35.46NAV (as of 4/25/2018)
  • +0.15 (+0.42%) NAV Change
  • HealthMorningstar Category
  • Global Health/Biotechnology FundsLipper Classification

Objective

Seeks long-term capital appreciation.

Overview

A stock fund that invests exclusively in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

More About Healthcare Fund 

The Health-Care Revolution

The health-care sector is undergoing dramatic changes that will impact everything from the drugs we take to the way patients’ medical records are shared. Aging demographics globally and rising prosperity in emerging-market nations will drive even greater demand for lifesaving drugs, innovative procedures, and disruptive medical technology.

Pipeline to Innovation

With innovation and breakthroughs taking place across the globe, the Fund uses a broadly diversified, global approach that seeks to identify companies with the greatest opportunities in areas including biotechnology, medical technology, health services, and pharmaceuticals.

Backed by Size, Scale, and Experience

Wellington Management, the Fund’s sub-adviser, is one of the largest managers of health care stocks in the world. The portfolio managers on the Fund average 26 years of experience.

Jean M. Hynes, CFA
Senior Managing Director
Global Industry Analyst
view bio
Ann C. Gallo
Senior Managing Director
Global Industry Analyst
view bio
Robert L. Deresiewicz
Senior Managing Director
Global Industry Analyst
view bio

Portfolio managers are supported by the full resources of Wellington Management.

Performance

Performance (%)
% (as of 3/31/2018)
Average Annual Total Returns % (as of 3/31/2018)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare  I 1.62 9.94 5.41 16.04 13.33 11.73
Benchmark -0.50 12.35 6.17 14.47 12.68 ---
Morningstar Health Category 1.61 14.01 3.31 14.83 13.21 ---
Performance (%)
% (as of 3/31/2018)
Average Annual Total Returns % (as of 3/31/2018)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare  I 1.62 9.94 5.41 16.04 13.33 11.73
Benchmark -0.50 12.35 6.17 14.47 12.68 ---
Morningstar Health Category 1.61 14.01 3.31 14.83 13.21 ---
SI = Since Inception. Fund Inception: 05/01/2000
Operating Expenses:   Net  1.03% |  Gross  1.03%

Share Class Inception: 8/31/06.
Class I-share performance prior to its inception date reflects Class A-share performance (excluding sales charges) and operating expenses. SI performance is calculated from 5/1/00.

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

Growth of $10,000

(as of 3/31/2018)
[{"date":"2018/03/31","value":"33980"},{"date":"2018/02/28","value":"34349"},{"date":"2018/01/31","value":"35686"},{"date":"2017/12/31","value":"33451"},{"date":"2017/11/30","value":"33611"},{"date":"2017/10/31","value":"33023"},{"date":"2017/09/30","value":"33980"},{"date":"2017/08/31","value":"33895"},{"date":"2017/07/31","value":"33554"},{"date":"2017/06/30","value":"33488"},{"date":"2017/05/31","value":"31716"},{"date":"2017/04/30","value":"31451"},{"date":"2017/03/31","value":"30987"},{"date":"2017/02/28","value":"30835"},{"date":"2017/01/31","value":"28798"},{"date":"2016/12/31","value":"27510"},{"date":"2016/11/30","value":"27283"},{"date":"2016/10/31","value":"26571"},{"date":"2016/09/30","value":"28923"},{"date":"2016/08/31","value":"28373"},{"date":"2016/07/31","value":"29824"},{"date":"2016/06/30","value":"28167"},{"date":"2016/05/31","value":"28039"},{"date":"2016/04/30","value":"27112"},{"date":"2016/03/31","value":"26339"},{"date":"2016/02/29","value":"25610"},{"date":"2016/01/31","value":"26168"},{"date":"2015/12/31","value":"30090"},{"date":"2015/11/30","value":"29955"},{"date":"2015/10/31","value":"28916"},{"date":"2015/09/30","value":"27108"},{"date":"2015/08/31","value":"29521"},{"date":"2015/07/31","value":"31756"},{"date":"2015/06/30","value":"30739"},{"date":"2015/05/31","value":"30411"},{"date":"2015/04/30","value":"28573"},{"date":"2015/03/31","value":"29238"},{"date":"2015/02/28","value":"28707"},{"date":"2015/01/31","value":"27482"},{"date":"2014/12/31","value":"26705"},{"date":"2014/11/30","value":"26476"},{"date":"2014/10/31","value":"25547"},{"date":"2014/09/30","value":"23935"},{"date":"2014/08/31","value":"24221"},{"date":"2014/07/31","value":"23230"},{"date":"2014/06/30","value":"23621"},{"date":"2014/05/31","value":"22707"},{"date":"2014/04/30","value":"21960"},{"date":"2014/03/31","value":"22644"},{"date":"2014/02/28","value":"23398"},{"date":"2014/01/31","value":"21946"},{"date":"2013/12/31","value":"21122"},{"date":"2013/11/30","value":"20675"},{"date":"2013/10/31","value":"19579"},{"date":"2013/09/30","value":"18909"},{"date":"2013/08/31","value":"18148"},{"date":"2013/07/31","value":"18511"},{"date":"2013/06/30","value":"17171"},{"date":"2013/05/31","value":"17339"},{"date":"2013/04/30","value":"16983"},{"date":"2013/03/31","value":"16375"},{"date":"2013/02/28","value":"15405"},{"date":"2013/01/31","value":"15224"},{"date":"2012/12/31","value":"14135"},{"date":"2012/11/30","value":"14114"},{"date":"2012/10/31","value":"14037"},{"date":"2012/09/30","value":"14372"},{"date":"2012/08/31","value":"13744"},{"date":"2012/07/31","value":"13639"},{"date":"2012/06/30","value":"13695"},{"date":"2012/05/31","value":"13018"},{"date":"2012/04/30","value":"13479"},{"date":"2012/03/31","value":"13514"},{"date":"2012/02/29","value":"12844"},{"date":"2012/01/31","value":"12641"},{"date":"2011/12/31","value":"11803"},{"date":"2011/11/30","value":"11643"},{"date":"2011/10/31","value":"11727"},{"date":"2011/09/30","value":"11008"},{"date":"2011/08/31","value":"11741"},{"date":"2011/07/31","value":"12299"},{"date":"2011/06/30","value":"12934"},{"date":"2011/05/31","value":"13130"},{"date":"2011/04/30","value":"12641"},{"date":"2011/03/31","value":"11880"},{"date":"2011/02/28","value":"11517"},{"date":"2011/01/31","value":"11196"},{"date":"2010/12/31","value":"10959"},{"date":"2010/11/30","value":"10345"},{"date":"2010/10/31","value":"10617"},{"date":"2010/09/30","value":"10463"},{"date":"2010/08/31","value":"9444"},{"date":"2010/07/31","value":"9765"},{"date":"2010/06/30","value":"9626"},{"date":"2010/05/31","value":"10031"},{"date":"2010/04/30","value":"10666"},{"date":"2010/03/31","value":"11105"},{"date":"2010/02/28","value":"10491"},{"date":"2010/01/31","value":"10498"},{"date":"2009/12/31","value":"10303"},{"date":"2009/11/30","value":"9933"},{"date":"2009/10/31","value":"9123"},{"date":"2009/09/30","value":"9640"},{"date":"2009/08/31","value":"9409"},{"date":"2009/07/31","value":"9060"},{"date":"2009/06/30","value":"8551"},{"date":"2009/05/31","value":"8390"},{"date":"2009/04/30","value":"7783"},{"date":"2009/03/31","value":"7692"},{"date":"2009/02/28","value":"7315"},{"date":"2009/01/31","value":"8313"},{"date":"2008/12/31","value":"8481"},{"date":"2008/11/30","value":"7790"},{"date":"2008/10/31","value":"8410"},{"date":"2008/09/30","value":"10225"},{"date":"2008/08/31","value":"11107"},{"date":"2008/07/31","value":"11014"},{"date":"2008/06/30","value":"10391"},{"date":"2008/05/31","value":"10815"},{"date":"2008/04/30","value":"10424"},{"date":"2008/03/31","value":"10000"}]

 
Growth of $10,000

Reflects Class A, excluding sales charges. If sales charges and taxes had been included, the value would have been lower. Results for other classes will vary.

   

I-Share Morningstar Ratings
(as of 3/31/2018)
  • Overall
    infoIcon:
  • Overall Morningstar Rating for Healthcare Fund, Class I, as of 3/31/2018 out of 128 products in the Health Category Based on Risk-Adjusted Returns

Morningstar Analyst Rating

Bronze

Morningstar awarded the Fund a Bronze analyst rating on 4/3/181

Calendar Year Returns (%)
Fund Benchmark
2017 21.94 22.47
2016 -8.33 -2.05
2015 12.97 7.41
2014 26.80 24.79
2013 49.95 42.19
2012 20.14 18.35
2011 8.03 11.88
2010 6.69 5.20
2009 21.74 20.76
2008 -25.27 -23.76

Excludes sales charges. If sales charges and taxes had been included, the value would have been lower.

Characteristics Holdings are subject to change. Percentages may be rounded.

Statistics
As of Date 3/31/2018
Net Assets $1.4 billion
# of Holdings 112
Beta 1.14
R Squared 0.92
% in Equities 98%
Turnover (3/31/2018) 22%
% in Foreign Equities 13%
Standard Deviation 15.93%
Holdings Characteristics
(as of 3/31/2018)
Fund S&P Composite 1500 Health Care Index
Asset Weighted Market Cap $47.8 billion $112.5 billion
EPS Growth Rate 18.7% 10.1%
Median Market Cap $4.9 billion $3.7 billion
Price/Book 3.5x 3.9x
Price/Earnings 35.4x 14.6x
Return on Equity -1.1% 22.2%
Return Characteristics
(as of 3/31/2018)
Fund
Alpha -0.18
Down Capture 110.36
Information Ratio 0.33
Sharpe Ratio 1.10
Up Capture 114.00
Market Cap Distribution %
(as of 03/31/2018)
Less than $2 billion 16.5
$2 billion - $5 billion 11.1
$5 billion - $10 billion 8.2
Greater than $10 billion 64.2

Top Ten Holdings (%)

(as of 3/31/2018)
label percentageholding
UnitedHealth Group, Inc. 5.70
Medtronic plc 4.32
Bristol-Myers Squibb Co. 4.19
Allergan plc 3.25
Boston Scientific Corp. 2.83
Stryker Corp. 2.70
Thermo Fisher Scientific, Inc. 2.55
Eli Lilly & Co. 2.39
AstraZeneca plc 2.33
Abbott Laboratories 2.16
Total Portfolio % 32.42
(as of 12/31/2017)
label percentageholding
UnitedHealth Group, Inc. 6.39
Medtronic plc 4.71
Bristol-Myers Squibb Co. 4.31
Allergan plc 3.37
Celgene Corp. 3.13
Eli Lilly & Co. 2.89
Stryker Corp. 2.87
Boston Scientific Corp. 2.84
Thermo Fisher Scientific, Inc. 2.60
AstraZeneca plc 2.55
Total Portfolio % 35.66

Excel Full Portfolio Holdings Excel         PDF Full Portfolio Holdings

Fund Essentials
Inception Date 05/01/2000
Symbol HGHIX
CUSIP 416649887
Fund Number 1309

Subsector Exposure

(as of 3/31/2018)
label currentpercentage
Biopharma Mid Cap 20%
Biopharma Small Cap 11%
Health Care Services 23%
Medical Technology 26%
Biopharma Large Cap 20%
(as of 12/31/2017)
label currentpercentage
Biopharma Mid Cap 16%
Biopharma Small Cap 9%
Health Care Services 24%
Medical Technology 26%
Biopharma Large Cap 25%

Based on sub-adviser’s classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap.  Excludes cash. May not total to 100% due to rounding.

Insights

pdf

The 5-Minute Forecast 2Q18 

Wed Apr 18 11:24:00 EDT 2018
A concise summary of the Hartford Funds Multi-Asset Team’s views on the main challenges facing investors: Growth, Income, Volatility, Inflation, and Taxes.
pdf

Client Conversations: HSAs: 1 Account, 3 Tax Benefits 

Thu Feb 15 12:00:00 EST 2018
Have a health savings account, but not contributing to it? You could be missing out.
pdf

2018 Outlooks (Schroders) 

Fri Dec 22 14:06:00 EST 2017
Thought leaders from Schroder Investment Management provide their outlook on issues that may influence markets and portfolios going forward.

Literature

Fund Literature

Select All

email pdf
pdf

Fact Sheet

03/31/2018 | pdf
Get FINRA Letter

Max 100
pdf

Commentary

03/31/2018 | pdf
Get FINRA Letter

Max 100
pdf

Expanded Commentary

03/31/2018 | pdf

Max 100
pdf

Summary Prospectus

03/01/2018 | pdf

Available For
Download Only
pdf

Pitchbook

03/31/2018 | pdf

Available For
Download Only
pdf

Semi Annual Report

04/30/2017 | pdf

Available For
Download Only
pdf

Statutory Prospectus

03/01/2018 | pdf

Available For
Download Only
pdf

Annual Report

10/31/2017 | pdf

Available For
Download Only
pdf

Fund Story

03/31/2018 | pdf
Get FINRA Letter

Max 100
pdf

SAI

03/01/2017 | pdf

Available For
Download Only

Financial Professionals:

Log in to order forms and literature and manage your subscriptions.

Manage Subscriptions

View Cart

A WORD ABOUT RISK

Investing involves risk, including the possible loss of principal. There is no guarantee a fund will achieve its stated objective. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. • Risks of focusing investments on the healthcare related sector include regulatory and legal developments, patent considerations, intense competitive pressures, rapid technological changes, potential product obsolescence, and liquidity risk. • Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political and economic developments. These risks may be greater for investments in emerging markets. • Small- and mid-cap securities can have greater risks and volatility than large-cap securities.

1 The Morningstar Analyst Rating is not a credit or risk rating. It is a subjective evaluation performed by the manager research analysts of Morningstar. Morningstar evaluates funds based on five key pillars, which are process, performance, people, parent, and price. Analysts use this five pillar evaluation to determine how they believe funds are likely to perform over the long term on a risk-adjusted basis. They consider quantitative and qualitative factors in their research, and the weighting of each pillar may vary. The Analyst Rating scale is Gold, Silver, Bronze, Neutral, Negative. A Morningstar Analyst Rating of Gold, Silver, or Bronze reflects an Analyst’s conviction in a fund’s prospects for outperformance. Analyst Ratings are continuously monitored and reevaluated at least every 14 months. The Morningstar Analyst Rating should not be used as the sole basis in evaluating a mutual fund. Morningstar Analyst Ratings involve unknown risks and uncertainties which may cause Morningstar’s expectations not to occur or to differ significantly from what we expected. For more detailed information about Morningstar’s Analyst rating, including its methodology, please go to hartfordfunds.com/MorningstarAnalystMethodology.

© 2018 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

206254

The material on this site is for informational and educational purposes only. The material should not be considered tax or legal advice and is not to be relied on as a forecast. The material is also not a recommendation or advice regarding any particular security, strategy or product. Hartford Funds does not represent that any products or strategies discussed are suitable for any particular investor so investors should seek their own professional advice before investing. Hartford Funds does not serve as a fiduciary. Content is current as of the publication date or date indicated, and may be superseded by subsequent market and economic conditions.

All investments are subject to risk, including the possible loss of principal. Investors should carefully consider a fund's investment objectives, risks, charges and expenses. This and other important information is contained in the mutual fund, ETF or exchange-traded managed fund (ETMF) prospectus and summary prospectus, which can be obtained from a financial professional and should be read carefully before investing.

Mutual funds are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA/SIPC. Exchange-traded products are distributed by ALPS Distributors, Inc. (ALPS). Advisory services are provided by Hartford Funds Management Company, LLC (HFMC) and its wholly owned subsidiary, Lattice Strategies, LLC (Lattice). Certain funds are sub-advised by Wellington Management Company LLP or Schroder Investment Management North America Inc. Schroder Investment Management North America Ltd. serves as a secondary sub-adviser to certain funds. Hartford Funds refers to Hartford Funds Management Group, Inc. and its subsidiaries, including HFD, HFMC, and Lattice, which are not affiliated with any sub-adviser or ALPS. The funds and other products referred to on this Site may be offered and sold only to persons in the United States and its territories.

© Copyright 2018 Hartford Funds Management Group, Inc. All Rights Reserved. Not FDIC Insured | No Bank Guarantee | May Lose Value